Reliance Runs Ahead of Steel Peers as Analysts Lift Targets

The analyst community has been moving in the same direction, and recently. JP Morgan raised its target to $378 from $345, maintaining Neutral, in an action filed Tuesday. Wells Fargo lifted its target to $376 from $343 last week, also holding Equal-Weight. Those two moves continue a pattern that has run through late April — nearly every firm that touched the stock raised its target, with no downgrades and no cuts. The consensus mean target is $364, still roughly 9% below the current price, which means the Street has been chasing the stock upward with targets rather than leading it. Bulls point to earnings beats and forward estimate momentum — the EPS surprise factor scores in the 72nd percentile and 90-day earnings momentum in the 70th. Bears, reflected in the cluster of Neutral and Equal-Weight ratings, appear more focused on valuation: the PE is running near 19.8x and EV/EBITDA near 12.9x, both expanding over the past 30 days as the stock has rallied. The dividend factor is a standout at the 99th percentile, though the most recent dividend data in the snapshot is dated and should not be relied upon for yield calculations.

The positioning picture reinforces the idea that bears are absent rather than merely quiet. Short interest has fallen roughly 21% over the past month, now sitting at just 1.5% of the free float — a low absolute level with limited directional conviction from the short side. Borrowing costs are minimal at 0.30%, down sharply from levels closer to 0.50% earlier in May. Most tellingly, borrow availability is exceptionally loose: availability stands at over 4,400% of short interest, meaning there are approximately 44 shares available to borrow for every one currently lent out. The ORTEX short score of 31 sits toward the low end of the range, confirming there is no meaningful short-side pressure building. Options positioning leans the same way — the put/call ratio is running at 0.44, modestly below its 20-day average of 0.53, pointing to slightly more call than put activity. It is a notable shift from earlier in May when the PCR was running close to 0.88 for several sessions in a row. That hedging demand has largely unwound.

The insider picture is worth a brief note. CFO Arthur Ajemyan sold approximately $1.25 million in stock on April 27, at prices ranging from $357 to $359. The sales were at sizes typical of planned disposition programs and carry low trade-significance scores. There was no offsetting buying, but the stock has since traded up roughly 12% from those levels, making the sales look purely routine in hindsight.

The next scheduled catalyst is the Q2 earnings release on July 23. Recent prints have been mild movers — the May 20 result produced a 2.0% one-day gain and 5.8% over the following five days, while the April 22 release saw a 2.5% day-one move followed by nearly 7% over the week after. The pattern suggests Reliance tends to see a positive drift following results rather than a sharp gap. With Q3 now approaching and the stock already 8% ahead of the pack over the past month, the July 23 print becomes less a question of whether the company can beat and more a question of whether a stock trading above consensus targets can sustain the premium it has built.